Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: Results from the exploratory, controlled, randomized, international phase 2 IMPULSE study

Thomas, M; Ponce-Aix, S; Navarro, A; Riera-Knorrenschild, J; Schmidt, M; Wiegert, E; Kapp, K; ... IMPULSE study team, ; + view all Thomas, M; Ponce-Aix, S; Navarro, A; Riera-Knorrenschild, J; Schmidt, M; Wiegert, E; Kapp, K; Wittig, B; Mauri, C; Dómine Gómez, M; Kollmeier, J; Sadjadian, P; Fröhling, K-P; Huber, R; Wolf, M; IMPULSE study team, ; - view fewer (2018) Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: Results from the exploratory, controlled, randomized, international phase 2 IMPULSE study. Annals of Oncology , Article mdy326. 10.1093/annonc/mdy326 . (In press). Green open access

https://ift.tt/2NycBYV